Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm
about
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyMechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody.
P2860
Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@ast
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@en
type
label
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@ast
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@en
prefLabel
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@ast
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@en
P2093
P2860
P1476
Cytokine release assays for th ...... ive for TGN1412 cytokine storm
@en
P2093
D Eastwood
R Stebbings
S J Thorpe
S Vessillier
P2860
P356
10.1016/J.JIM.2015.04.020
P50
P577
2015-05-07T00:00:00Z